- Home
- GOOD vs IAM Comparison
GOOD vs IAM Comparison
Compare GOOD & IAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$9.98
N/A
Current Price
$13.43
Company Overview
Basic Information| Metric | GOOD | IAM |
|---|---|---|
| Founded | 2003 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.9M | 683.0M |
| IPO Year | 2003 | 2026 |
Fundamental Metrics
Financial Performance| Metric | GOOD | IAM |
|---|---|---|
| Price | $9.98 | $13.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $12.88 | ★ $27.25 |
| AVG Volume (30 Days) | ★ 673.7K | 624.7K |
| Earning Date | 11-03-2026 | 11-27-2026 |
| Dividend Yield | ★ 12.18% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $161,336,000.00 | N/A |
| Revenue This Year | $5.86 | $225.80 |
| Revenue Next Year | $1.99 | $190.68 |
| P/E Ratio | $123.88 | ★ N/A |
| Revenue Growth | ★ 8.00 | N/A |
| 52 Week Low | $9.89 | $9.60 |
| 52 Week High | $13.28 | $24.49 |
Technical Indicators
Market Signals| Indicator | GOOD | IAM |
|---|---|---|
| Relative Strength Index (RSI) | 22.02 | 30.47 |
| Support Level | N/A | $12.52 |
| Resistance Level | $13.07 | $15.44 |
| Average True Range (ATR) | 0.35 | 1.90 |
| MACD | -0.12 | 0.40 |
| Stochastic Oscillator | 11.80 | 54.35 |
Price Performance
Historical Comparison GOOD
IAM
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About IAM Iambic Therapeutics Inc. Common Stock
Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.